Press releases

• May 26, 2020 - Regulatory press releaseMembers of BioArctic’s Board of Directors and management increase their shareholdings
• May 7, 2020 - Regulatory press releaseReport from Annual General Meeting in BioArctic (publ)
• April 22, 2020 - Regulatory press releaseInterim Report for the period January – March 2020

Archive

Calendar

• June 2, 2020Redeye Growth Day
• June 4, 2020Jefferies Global Healthcare Conference
• July 10, 2020 08:00 CETInterim report January – June 2020
• October 14, 2020 08:00 CETInterim report January – September 2020
• February 4, 2021 08:00 CETFull Year Report January – December 2020

Interim Report January – March 2020

BioArctic published the company’s Interim Report for the period January – March 2020 on Wednesday, April 22, 2020 at 08:00 a.m. CEST.

• Webcast
• Report
• Press release
• Presentation

Read the report

Alzheimer’s disease

Halting the disease progression would lead to great benefits to patients, families and caregivers.

Read more

Parkinson’s disease

The medical need of treatments is high due to the lack of drugs affecting the underlying pathology.

Read more

Neurodegenerative disorders

BioArctic is committed to help people with neurodegenerative disorders

Read more